Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zogenix (ZGNX) and OrthoPediatrics (KIDS).
Zogenix (ZGNX)
In a report released today, Danielle Brill from Raymond James maintained a Hold rating on Zogenix. The company’s shares closed last Monday at $21.07, close to its 52-week low of $16.65.
According to TipRanks.com, Brill is a 5-star analyst with an average return of 20.4% and a 59.7% success rate. Brill covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, ACADIA Pharmaceuticals, and Sarepta Therapeutics.
Zogenix has an analyst consensus of Moderate Buy, with a price target consensus of $48.25.
See today’s analyst top recommended stocks >>
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
